Effect of SGRQ-Defined Chronic Bronchitis at Baseline on Treatment Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate

BACKGROUND: Chronic bronchitis (CB) is one of the conditions that contribute to chronic obstructive pulmonary disease (COPD). Despite its widespread prevalence among patients with COPD and overall negative impact on treatment outcomes, the effect of CB on the efficacy of bronchodilator therapy has n...

Descripción completa

Detalles Bibliográficos
Autores principales: Tashkin, Donald P, Ozol-Godfrey, Ayca, Sharma, Sanjay, Sanjar, Shahin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051958/
https://www.ncbi.nlm.nih.gov/pubmed/33880019
http://dx.doi.org/10.2147/COPD.S304182

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8051958/
https://www.ncbi.nlm.nih.gov/pubmed/33880019
http://dx.doi.org/10.2147/COPD.S304182

Ejemplares similares